BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25317032)

  • 1. Edaravone injected at the start of reperfusion suppresses myonephropathic metabolic syndrome in rats.
    Yamamura M; Miyamoto Y; Mitsuno M; Tanaka H; Ryomoto M
    Int J Angiol; 2014 Sep; 23(3):193-6. PubMed ID: 25317032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with the Free Radical Scavenger Edaravone Mitigates Kidney Glycogen Depletion and Neutrophil Infiltration after Leg Ischemia in a Rat Model: A Pilot Study.
    Yamamura M; Miyamoto Y; Mitsuno M; Tanaka H; Ryomoto M
    Ann Vasc Dis; 2017 Dec; 10(4):417-422. PubMed ID: 29515706
    [No Abstract]   [Full Text] [Related]  

  • 3. Edaravone Suppresses Reperfusion Injury following Leg Ischemia in Rats: A Transmission Electron Microscopic Study.
    Yamamura M; Miyamoto Y; Mitsuno M; Tanaka H; Ryomoto M; Fukui S
    Int J Angiol; 2013 Dec; 22(4):267-70. PubMed ID: 24436626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edaravone protects against tissue damage in the lung and kidney induced by myonephropathic metabolic syndrome.
    Yamamura M; Miyamoto Y; Mitsuno M; Tanaka H; Ryomoto M
    Int J Angiol; 2010; 19(1):e38-40. PubMed ID: 22477573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edaravone suppresses postoperative reperfusion injury in rat lower extremity: An immunohistological study.
    Yamamura M; Miyamoto Y; Mitsuno M; Ohata T; Tanaka H; Kobayashi Y; Ryomoto M; Yoshioka Y
    Int J Angiol; 2007; 16(1):17-9. PubMed ID: 22477243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Edaravone reduces mitochondrial damage due to reperfusion injury following leg ischemia in rats.
    Yamamura M; Miyamoto Y; Mitsuno M; Tanaka H; Ryomoto M; Fukui S; Yoshioka Y
    Int J Angiol; 2010; 19(4):e129-31. PubMed ID: 22479143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edaravone attenuates lung injury in a hind limb ischemia-reperfusion rat model: A histological, immunohistochemical and biochemical study.
    Kassab AA; Aboregela AM; Shalaby AM
    Ann Anat; 2020 Mar; 228():151433. PubMed ID: 31678401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edaravone suppresses endothelial cell injury in vein grafts of a rat model.
    Yamamura M; Mitsuno M; Tanaka H; Kobayashi Y; Fukui S; Miyamoto Y
    Int J Angiol; 2008; 17(4):221-2. PubMed ID: 22477455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of postoperative intimal hyperplasia of vein grafts with edaravone in rat models - a scanning electron microscope study.
    Yamamura M; Miyamoto Y; Mitsuno M; Tanaka H; Kobayashi Y; Ryomoto M
    Int J Angiol; 2007; 16(4):143-5. PubMed ID: 22477331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edaravone enhances the viability of ischemia/reperfusion flaps.
    Zhang DY; Kang SS; Zhang ZW; Wu R
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):51-56. PubMed ID: 28224430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A free radical scavenger but not FGF-2-mediated angiogenic therapy rescues myonephropathic metabolic syndrome in severe hindlimb ischemia.
    Kaneko K; Yonemitsu Y; Fujii T; Onimaru M; Jin CH; Inoue M; Hasegawa M; Onohara T; Maehara Y; Sueishi K
    Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1484-92. PubMed ID: 16301206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edaravone, a newly developed radical scavenger, protects against ischemia-reperfusion injury of the small intestine in rats.
    Tomatsuri N; Yoshida N; Takagi T; Katada K; Isozaki Y; Imamoto E; Uchiyama K; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
    Int J Mol Med; 2004 Jan; 13(1):105-9. PubMed ID: 14654979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of edaravone for tourniquet-induced ischemia-reperfusion injury on skeletal muscle in murine hindlimb.
    Hori K; Tsujii M; Iino T; Satonaka H; Uemura T; Akeda K; Hasegawa M; Uchida A; Sudo A
    BMC Musculoskelet Disord; 2013 Mar; 14():113. PubMed ID: 23530927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of edaravone, a free-radical scavenger, on ischaemia-reperfusion injury in the rat testis.
    Tamamura M; Saito M; Kinoshita Y; Shimizu S; Satoh I; Shomori K; Dimitriadis F; Satoh K
    BJU Int; 2010 Mar; 105(6):870-6. PubMed ID: 19694712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new free radical scavenger, edaravone, ameliorates oxidative liver damage due to ischemia-reperfusion in vitro and in vivo.
    Abe T; Unno M; Takeuchi H; Kakita T; Katayose Y; Rikiyama T; Morikawa T; Suzuki M; Matsuno S
    J Gastrointest Surg; 2004; 8(5):604-15. PubMed ID: 15239999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edaravone protects against ischemia/reperfusion-induced functional and biochemical changes in rat urinary bladder.
    Matsumoto S; Hanai T; Yoshioka N; Shimizu N; Sugiyama T; Uemura H; Levin RM
    Urology; 2005 Oct; 66(4):892-6. PubMed ID: 16230177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCI-186 (edaravone), a free radical scavenger, attenuates ischemia-reperfusion injury and activation of phospholipase A(2) in an isolated rat lung model after 18 h of cold preservation.
    Reyes YA; Shimoyama T; Akamatsu H; Sunamori M
    Eur J Cardiothorac Surg; 2006 Mar; 29(3):304-11. PubMed ID: 16427299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategy for prevention of myonephropathic metabolic syndrome (MNMS): comparison of cooling and perfusion.
    Oue H; Sugimoto T; Okada M
    Kobe J Med Sci; 1999 Feb; 45(1):13-25. PubMed ID: 10487032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edaravone reduces ischemia-reperfusion injury mediators in rat liver.
    Taniguchi M; Uchinami M; Doi K; Yoshida M; Sasaki H; Tamagawa K; Horiuchi T; Tanaka K
    J Surg Res; 2007 Jan; 137(1):69-74. PubMed ID: 17064733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edaravone protects against lung injury induced by intestinal ischemia/reperfusion in rat.
    Ito K; Ozasa H; Horikawa S
    Free Radic Biol Med; 2005 Feb; 38(3):369-74. PubMed ID: 15629865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.